Hiring a Healthcare Marketing Agency Before Defining Your Category Burns 12 Months of Medtech Runway

Key Takeaways

• Most healthcare marketing agencies are built for demand capture (paid search, retargeting, conversion-rate optimisation) when pre-traction medtech needs demand creation instead
• Clinical validation, FDA clearance, and physician champions do not produce commercial traction on their own
• Market engineering precedes go-to-market: category, then messaging, then narrative, then sales motion
• The diagnostic for a broken market is when every founder-to-customer conversation requires education, reframing, or basic re-positioning
• Pre-Series-A medtech founders should evaluate agencies on category design capability, not campaign-execution capacity

You got FDA clearance. You have a clinical study. You have three physician champions who genuinely love what you built.

And every conversation with a buyer, investor, or strategic still ends with some version of "interesting, keep us posted."

So most founders read that as a sales problem or a fundraising problem. But the actual diagnosis is structural. You don't have a marketing problem in the way a healthcare marketing agency typically defines one.

This post lays out what's broken when pre-traction medtech companies stall, why most healthcare marketing agencies are built to solve the wrong problem, and what founders should evaluate agencies on instead.

Why Most Healthcare Marketing Agencies Get Medtech Wrong

Most healthcare marketing agencies are built around a core capability stack: paid media, content production, conversion-rate optimisation, marketing automation, and reporting.

That stack is excellent at one job. It captures demand that already exists.

The problem for pre-traction medtech is that the demand doesn't exist yet. You're not competing for share inside an established category. You're trying to convince clinicians, payers, and acquirers that a category exists at all.

I've sat through 370+ episodes of The State of MedTech. Founders who hit this wall tell the same story.

Clearance lands. The board expects acceleration. The team adds reps, ramps content output, books more conferences. And nothing moves.

I covered this directly on a recent solo episode about market engineering for medtech startups raising capital:

"Most MedTech founders don't exactly have a demand problem. What they have is really a definition problem. Until you actually define a market clearly, you're not actually able to get any traction."

So when you sign with a healthcare marketing agency at this stage, you usually hire execution capacity for a problem you don't have yet.

The campaigns ship on time. The landing pages convert at industry averages. And six months later, you still can't predict whether a deal will close.

What Market Engineering Does

Market engineering is the discipline of building the conditions for demand before scaling commercial execution. It sits upstream of go-to-market. The four components run in sequence: category, then messaging, then narrative, then go-to-market.

Category is the unit of competition.

Before you build the market, you have to name what game is being played, who the players are, and what wins.

Without that, every buyer asks the same first question: "which existing thing are you like?" And the answer to that question almost always loses.

On the same market engineering episode, I broke the framework down into operating components:

"Your category is defining the problem, naming the category. Messaging is your positioning, your differentiation, your proofs. Narrative, that's thought leadership, your point of view, market education. Then go-to-market is sales and demand generation. Most medtech companies skip those first three steps and go straight to go-to-market."

The skipped steps are why agency engagements stall.

Hand a demand-gen team a product without a clear category, sharp messaging, or a defensible narrative. They can run beautiful campaigns and still produce zero pipeline. The mechanism for adoption isn't there yet.

Bruce Cleveland at Traction Gap Partners has been making this point for over a decade. The companies that win categories engineer them deliberately, the same way they engineer their products.

When I sat down with Nick Damiano of Avant Surgical on an episode about autonomous surgery and the future of robotics, I made the case more bluntly:

"Clinical validation is not adoption. FDA clearance is not demand. And innovation alone does not create a category."

Reading those three sentences as a medtech founder is uncomfortable on purpose.

Most of the budget pre-clearance goes toward proving exactly those three things. And every one of them is necessary. But none is sufficient.

Demand Creation vs Demand Capture: The Misallocation Problem

The single most expensive mistake in medtech marketing is mistaking demand capture for demand creation.

They use the same channels.

They show up on the same dashboards. They look identical in attribution reports. The difference only shows up when you track what each was built to do.

I covered this distinction on the $90M medtech sales blind spot episode with an analogy that's been the easiest way to get founders to feel the gap:

"When I think marketing, demand generation, then in an ideal world, as you generate the demand, you also need to capture it. It's almost like lobbing a baseball really high up in the air. You've got to jog over to where it's going to land. Most of the budget goes to the catching, not the throwing."

So if your last quarter's CRM shows leads originating from paid search, that's a demand-capture metric.

Someone already knew enough about the category to type the search. The agency or channel that surfaced you at that moment did not create the demand. It captured demand that someone else, somewhere upstream, made.

This sounds like semantics. It changes how budget should be allocated, which agency capabilities matter, and how you measure whether the work is working.

On the 2023 review of MedTech sales and marketing in the digital age, I named the specific failure mode:

"There are things that are going to generate demand and things are going to capture demand. When you look at your CRM you might notice that a lot of your leads have come from Google AdWords. That's not the thing that generated demand. That's the thing that captured demand."

Pre-traction medtech is almost always over-indexed on capture and under-invested in creation. Capture is measurable inside a quarter.

Creation pays back over years.

Most healthcare marketing agencies are built around quarterly reporting cycles. So they sell what they can measure.

The Adoption Mechanism: Why Category Clarity Matters

Once you understand the demand creation problem, the adoption mechanism gets clearer. Different buyer types respond to different signals at different points in the adoption curve. Early adopters and the early majority are not the same audience.

I went deep on this dynamic on an episode about how medtech startups drive technology adoption to cross the chasm:

"Early adopters, they buy possibility. Early majority, they buy category clarity. If your category is not clear, the market's just not going to engage."

So you can sell the first ten deals on possibility.

But the next hundred require something different. Pragmatic buyers need to know which category you're in, who else operates there, and what the established evaluation criteria look like. If you haven't built that scaffolding, the early majority can't process your pitch.

They don't have anywhere to put you.

This is why mid-stage medtech companies often see velocity drop after the first wave of innovator champions. The KOL relationships were built on possibility. The next layer of buyers doesn't run on that fuel.

On the $100B exit fix episode about mini strategics, I used an analogy that's stuck with a lot of founders since:

"When you come up with a category, it's like coming up with a new sport. You want to pack the stadium. We want people to show up and watch. The category is essentially setting up the rules of the game, the context, the language, and everything."

A healthcare marketing agency that understands this difference operates differently.

They spend less time on conversion-rate optimisation and more time on category definition. They produce point-of-view content before they produce comparison-grid landing pages. And they measure success by whether the right vocabulary starts appearing in buyer conversations, not by whether last month's CPL dropped 8%.

When Founders Should Hire an Agency (and When They Shouldn't)

The right time to hire a healthcare marketing agency depends on which problem you have. There are three patterns I see at MarketCraft.

Pattern 1: you've engineered the market and you need scale.

Category is defined. Messaging is sharp. The narrative resonates with the buyers you want. Your pipeline is repeatable but not yet at the volume you need.

This is where a traditional healthcare marketing agency earns its fee. Hire them to execute paid media, content production, and conversion infrastructure. The work compounds.

Pattern 2: you have a product and clearance but no category.

Every deal feels custom. Every pitch requires educating the buyer.

Investors say "interesting" and pass. A demand-gen agency will not fix this. You need market engineering first.

This is the diagnostic I gave on the market engineering episode that holds up every time:

"If every one of your deals, even in the early days when you're founder and you're reaching out to a customer, if every single time it requires you educating or even having re-education, reframing, explaining basic things about the problem and the solution, that's not sales. It's literally missing the market."

Pattern 3: you have a category but the narrative is inconsistent.

Different team members tell different versions of the story. The website says one thing. The deck says another. The KOLs describe the product in a fourth way.

This is a narrative and messaging engagement. It's faster than full category design but doesn't fit the standard agency execution model either.

Most healthcare marketing agencies pitch every founder as if they're in Pattern 1. So if you're in Pattern 2 or 3, the engagement is structurally set up to fail.

For more on what disciplined commercial execution looks like once the market is engineered, read the full medtech commercialisation strategy framework. And for the operator-level view of how this thinking compounds into multi-billion-dollar outcomes, the medtech exit playbook covers what founders who got there did differently.

What Medtech Founders Should Ask Before Signing

Before you sign with any healthcare marketing agency, the conversation needs to surface five things. None of them are about case studies or campaign metrics.

First, ask them to articulate the difference between demand creation and demand capture. Then ask which one they're best at. If they say "both," they probably mean capture.

Second, ask them how they'd define your category if they had to write a one-paragraph market charter today. The answer tells you whether they think in categories or in campaigns.

Third, ask which medtech companies they've worked with at the pre-traction stage specifically. Healthcare is a broad term. Most agencies have B2C healthcare experience that doesn't translate to medtech B2B.

The buyer cycle, the regulatory context, and the KOL dynamics are fundamentally different. You need someone who's lived inside the medtech ecosystem.

Fourth, ask how they would know in 90 days whether the engagement is working. The honest answer is that category-building takes longer to show up in pipeline metrics.

So if they promise pipeline acceleration in 90 days, they're selling capture, not creation.

Fifth, ask them to tell you about a client they fired or turned down. Healthy agencies have boundaries. They know which engagements they're built to win.

The agencies that say yes to everything deliver Pattern-1 work regardless of which pattern you're in.

What This Means for Medtech Founders

In my experience working with medtech founders, the agency-selection conversation happens at the wrong time and for the wrong reasons. It happens after FDA clearance, when the board wants velocity.

And it gets framed as "we need someone to drive demand."

So that framing already locks in the wrong answer. The agency you'll evaluate against that brief is built to drive demand inside a category that already exists. If your category exists, that's a fine engagement.

But if it doesn't, you'll burn nine months of runway proving it. The campaigns will run. The reports will look clean. And without a defined category, none of it converts.

The question is whether you have a market to capture from in the first place.

If you do, hire for demand capture. If you don't, hire for market engineering. And if you can't tell which one you have, that's the diagnostic.

That's what we built MarketCraft to solve.

It's a market engineering practice that works upstream of the agency stack, so the demand-capture work that follows has something to capture.

Frequently Asked Questions

What does a healthcare marketing agency do?

A healthcare marketing agency typically provides paid media management, content production, marketing automation, search optimisation, and conversion-rate optimisation for healthcare brands.

The work is built around capturing existing demand from clinicians, patients, or healthcare buyers and converting it into qualified leads or revenue. The execution model is well-suited to companies with established categories and proven product-market fit.

How is a medtech marketing agency different from a general healthcare marketing agency?

A medtech marketing agency specialises in the B2B sales cycle, regulatory environment, and KOL dynamics specific to medical device companies. The buyer journey involves Value Analysis Committees, payer reimbursement, hospital procurement, and clinician champions.

A general healthcare marketing agency often has DTC pharmaceutical or hospital marketing experience that doesn't translate to medtech B2B, because the buyer set, evaluation criteria, and time-to-close are fundamentally different.

How much does a healthcare marketing agency cost?

Healthcare marketing agency retainers typically range from $10,000 to $50,000 per month depending on scope, channels managed, and the seniority of the strategists assigned.

Pre-traction medtech companies that need category design and market engineering work tend to fall in the $10,000 to $25,000 range with a smaller team operating closer to the founder. Agencies focused on demand capture at scale typically command higher retainers tied to media spend management.

When should a medtech founder hire a marketing agency?

The right time depends on whether the company has engineered its market. If the category is defined, the messaging is sharp, and the pipeline is repeatable but not yet at scale, a traditional demand-capture agency is the right call.

But if the company has clearance and every deal still requires founder-led education on the basic problem and solution, the company needs market engineering first. Demand-capture agency work on top of a poorly-defined market produces beautiful reporting and no measurable commercial traction.

Listen to the Full Conversations

The episodes referenced in this post are available on The State of MedTech. Subscribe wherever you listen to podcasts.

• How Market Engineering Helps MedTech Startups Raise Capital
• Autonomous Surgery and the Future of Robotics with Nick Damiano
• How MedTech Startups Drive Technology Adoption to Cross the Chasm
• The $90M Medtech Sales Blind Spot No One Talks About
• Manifest MedTech: 2023 Review on Sales & Marketing in the Digital Age
• $100B Exit Fix: How Mini Strategics Are Winning

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry. He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.